{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:08:52Z","timestamp":1788394132344,"version":"build-2803163510"},"reference-count":40,"publisher":"American Society for Microbiology","issue":"12","license":[{"start":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T00:00:00Z","timestamp":1671494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1128\/ASMCopyrightv2"},{"start":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T00:00:00Z","timestamp":1671494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/501100004587","name":"MEC | Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI18\/00814"],"award-info":[{"award-number":["PI18\/00814"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"MEC | Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI18\/00339"],"award-info":[{"award-number":["PI18\/00339"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Centro de Investigacion Biomedica en Red de Enfermedades Infecciosas","award":["CB\/13\/00009"],"award-info":[{"award-number":["CB\/13\/00009"]}]},{"name":"Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias","award":["CB06\/06\/0037"],"award-info":[{"award-number":["CB06\/06\/0037"]}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2022,12,20]]},"abstract":"<jats:p>To report on the therapy used for penicillin- and cephalosporin-resistant pneumococcal meningitis, we conducted an observational cohort study of patients admitted to our hospital with pneumococcal meningitis between 1977 and 2018. According to the European Committee on Antimicrobial Susceptibility Testing (EUCAST) recommendations, we defined pneumococci as susceptible and resistant to penicillin with MIC values of \u22640.06\u2009mg\/L and\u2009&gt;\u20090.06\u2009mg\/L, respectively; the corresponding values for cefotaxime (CTX) were \u22640.5\u2009mg\/L and &gt;0.5\u2009mg\/L.<\/jats:p>","DOI":"10.1128\/aac.00820-22","type":"journal-article","created":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T13:03:49Z","timestamp":1667480629000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":20,"title":["Penicillin- and Cephalosporin-Resistant Pneumococcal Meningitis: Treatment in the Real World and in Guidelines"],"prefix":"10.1128","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7392-7382","authenticated-orcid":true,"given":"Carmen","family":"Cabellos","sequence":"first","affiliation":[{"name":"Infectious Diseases Department, Hospital Universitari Bellvitge-IDIBELL, L\u2019Hospitalet de Llobregat, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica de Enfermedades Infecciosas (CIBERINFEC), ISCIII, Madrid, Spain"},{"name":"Departament de Ci\u00e8ncies Cl\u00edniques, University of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Llu\u00efsa","family":"Guillem","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, Hospital Universitari Bellvitge-IDIBELL, L\u2019Hospitalet de Llobregat, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica de Enfermedades Infecciosas (CIBERINFEC), ISCIII, Madrid, Spain"},{"name":"Departament de Ci\u00e8ncies Cl\u00edniques, University of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Pelegrin","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, Hospital Universitari Bellvitge-IDIBELL, L\u2019Hospitalet de Llobregat, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica de Enfermedades Infecciosas (CIBERINFEC), ISCIII, Madrid, Spain"},{"name":"Departament de Ci\u00e8ncies Cl\u00edniques, University of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fe","family":"Tubau","sequence":"additional","affiliation":[{"name":"Microbiology Department, Hospital Universitari Bellvitge-IDIBELL, L\u2019Hospitalet de Llobregat, Spain"},{"name":"CIBER de Enfermedades Respiratorias (CIBERes), ISCIII, Madrid, Spain"},{"name":"Department of Pathology and Experimental Therapeutics, University of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Ardanuy","sequence":"additional","affiliation":[{"name":"Microbiology Department, Hospital Universitari Bellvitge-IDIBELL, L\u2019Hospitalet de Llobregat, Spain"},{"name":"CIBER de Enfermedades Respiratorias (CIBERes), ISCIII, Madrid, Spain"},{"name":"Department of Pathology and Experimental Therapeutics, University of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Gudiol","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, Hospital Universitari Bellvitge-IDIBELL, L\u2019Hospitalet de Llobregat, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica de Enfermedades Infecciosas (CIBERINFEC), ISCIII, Madrid, Spain"},{"name":"Departament de Ci\u00e8ncies Cl\u00edniques, University of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Ariza","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, Hospital Universitari Bellvitge-IDIBELL, L\u2019Hospitalet de Llobregat, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica de Enfermedades Infecciosas (CIBERINFEC), ISCIII, Madrid, Spain"},{"name":"Departament de Ci\u00e8ncies Cl\u00edniques, University of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro F.","family":"Viladrich","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, Hospital Universitari Bellvitge-IDIBELL, L\u2019Hospitalet de Llobregat, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica de Enfermedades Infecciosas (CIBERINFEC), ISCIII, Madrid, Spain"},{"name":"Departament de Ci\u00e8ncies Cl\u00edniques, University of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2012.10.030"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00070-09"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(67)92346-X"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(77)92892-6"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(88)90061-7"},{"key":"e_1_3_2_7_2","first-page":"662","article-title":"Cephalosporin treatment failure in penicillin- and cephalosporin-resistant Streptococcus pneumoniae meningitis","volume":"11","author":"Sloas MM","year":"1992","unstructured":"Sloas MM, Barrett FF, Chesney PJ, English BK, Hill BC, Tenover FC, Leggiadro RJ. 1992. Cephalosporin treatment failure in penicillin- and cephalosporin-resistant Streptococcus pneumoniae meningitis. Pediatr Infect Dis J 11:662\u2013666.","journal-title":"Pediatr Infect Dis J"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.23.4.545"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/15.1.99"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199503303321317"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm839"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01454-08"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2010.03182.x"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.00486"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics8020041"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2018.03.004"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaa465"},{"key":"e_1_3_2_18_2","volume-title":"Antibiotic resistance threats in the United States, 2013","author":"CDC","year":"2019","unstructured":"CDC. 2019. Antibiotic resistance threats in the United States, 2013. Centers for Disease Control and Prevention, Atlanta, GA, USA."},{"key":"e_1_3_2_19_2","unstructured":"WHO. 2017. Global priority list of antibiotic-resistant bacteria to guide research discovery and development of new antibiotics."},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.35.12.2467"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.9.1988"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.40.1.218"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199709000-00014"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1086\/340400"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1086\/510390"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2013.09.012"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.37.8.1630"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.6.1320"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/49.3.507"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.6.1397"},{"key":"e_1_3_2_31_2","first-page":"2372","article-title":"Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis","volume":"43","author":"Friedland IR","year":"1999","unstructured":"Friedland IR, Paris M, Ehrett S. 1999. Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrob Agents Chemother 43:2372\u20132375.","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.7.2169-2172.2001"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.8.2487-2491.2003"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.10.3928-3933.2004"},{"key":"e_1_3_2_35_2","doi-asserted-by":"crossref","unstructured":"Ribes S Taberner F Domenech A Cabellos C Tubau F Li\u00f1ares J Viladrich PF Gudiol F. 2006. Evaluation of fosfomycin alone and in combination with CRO or vancomycin in an experimental model of meningitis caused by two strains of cephalosporin-resistant Streptococcus pneumoniae . 57:931\u2013936. doi:10.1093\/jac\/dkl047.","DOI":"10.1093\/jac\/dkl047"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1086\/425368"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2016.01.007"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/45.3.315"},{"key":"e_1_3_2_39_2","unstructured":"Soci\u00e9t\u00e9 de pathologie infectieuse de langue fran\u00e7aise (SPILF) organisateur de la 17e Conf\u00e9rence de consensus en th\u00e9rapeutique anti-infectieuse. 2008. Prise en charge des m\u00e9ningites bact\u00e9riennes aigu\u00ebs communautaires (\u00e0 l\u2019exclusion du nouveau-n\u00e9). http:\/\/www.infectiologie.com\/site\/medias\/_documents\/consensus\/2008-Meningites-court.pdf."},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dky553"},{"key":"e_1_3_2_41_2","unstructured":"The European Committee on Antimicrobial Susceptibility Testing. 2021. Breakpoint tables for interpretation of MICs and zone diameters. Version 11.0. http:\/\/www.eucast.org."}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/aac.00820-22","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/aac.00820-22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T14:08:37Z","timestamp":1671545317000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/aac.00820-22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,20]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12,20]]}},"alternative-id":["10.1128\/aac.00820-22"],"URL":"https:\/\/doi.org\/10.1128\/aac.00820-22","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,20]]},"assertion":[{"value":"2022-06-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-04","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-03","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00820-22"}}